India's Venus Remedies rises on UNICEF order
** Shares of India's Venus Remedies VENR.NS rise as much
as 8.7% to 385 rupees, currently up ~6%
** Pharma co receives order from United Nations Children's
Fund (UNICEF) for its antibiotic drug, Ceftriaxone 1gm
** Co did not disclose financial details of the order
** Trading vols 6.2x the 30-day avg
** VENR has lost 7.8% so far this year after surging 124% in
2023
(Reporting by Hritam Mukherjee in Bengaluru)
((Hritam.Mukherjee@thomsonreuters.com;))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage